+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Brain & Spinal Cord Cancer Market - Global Forecast 2026-2032- Product Image
Brain & Spinal Cord Cancer Market - Global Forecast 2026-2032- Product Image
New

Brain & Spinal Cord Cancer Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 188 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5968082
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Brain & Spinal Cord Cancer Market is evolving as complexities in clinical care, operational demands, and regulatory frameworks deepen. Senior leaders must make agile, evidence-based decisions within a landscape shaped by multidisciplinary advances, technology integration, and ongoing stakeholder pressures.

Market Snapshot: Brain & Spinal Cord Cancer Market

The global Brain & Spinal Cord Cancer Market is projected to grow from USD 4.21 billion in 2025, with a steady compound annual growth rate of 5.98%. Anticipated market value will reach USD 6.33 billion by 2032, driven by increased investment in clinical innovation and the wide adoption of advanced therapeutic pathways. Expanding demand for novel therapeutics, evolving supply chain strategies, and intensified regulatory oversight are key contributors to this trajectory. Market growth reflects the response to calls for resilient oncology care systems and the need for agile adaptation to ongoing operational and policy shifts.

Scope & Segmentation

This report offers decision-ready intelligence across critical market facets, supplying granular insight for informed strategic development and operational alignment:

  • Cancer Types: Astrocytoma, Ependymoma, Glioblastoma, Medulloblastoma, Meningioma, Oligodendroglioma, Schwannoma. Segment differentiation speaks to distinct biological behaviors and therapy requirements.
  • Treatment Modalities: Chemotherapy (Alkylating Agents, Nitrosoureas, Platinum-Based Agents), Immunotherapy (CAR T Cell Therapy, Checkpoint Inhibitors), Radiation Therapy (External Beam Radiation, Proton Therapy, Stereotactic Radiosurgery), Surgery (Craniotomy, Laser Ablation, Minimally Invasive Resection), Targeted Therapy (Kinase Inhibitors, Monoclonal Antibodies), Supportive Care. Advancements such as precision radiation and minimally invasive surgery are redefining standard approaches and improving care precision.
  • Patient Age Groups: Adult, Geriatric, Pediatric. Age-specific strategies are critical for tailored treatment planning and pathway optimization.
  • End Users: Hospitals, Cancer Clinics, Ambulatory Surgical Centers, Home Care Settings. Each setting offers differentiated opportunities for care model innovation and workflow design.
  • Distribution Channels: Hospital Pharmacies, Clinic Pharmacies, Retail Pharmacies, Online Pharmacies, Specialty Stores. Distribution choices impact therapy access, supply reliability, and delivery speed.
  • Regions: Americas, Europe, Middle East & Africa, Asia-Pacific. Regional differences shape market access, technology uptake, and system investment priorities.

Accelerated adoption of enabling technologies, including molecular diagnostics and digital health platforms, continues to transform clinical pathways and data-driven decision-making in each segment. Regional market ecosystems, shaped by unique policy and investment climates, further influence adoption speeds and patient access patterns.

Key Takeaways for Decision-Makers

  • Integrated neuro-oncology models now center on precision medicine, advanced diagnostics, and cross-specialty coordination, pushing operational processes and patient pathways toward greater efficiency.
  • Adoption of innovative therapies encounters variable access and reimbursement landscapes, requiring organizations to embrace localized supply chain strategies and value-based contracting.
  • Immunotherapies and minimally invasive surgical techniques expand the therapeutic arsenal but also bring multifaceted operational and compliance considerations to the fore.
  • Organizations optimizing pediatric and geriatric care, or scaling infrastructure for proton therapy and digital therapeutic solutions, are positioning themselves to meet emerging clinical demands and value creation goals.
  • Regional market characteristics such as regulatory stringency, investment incentives, and healthcare infrastructure maturity require nuanced stakeholder engagement and tailored go-to-market plans.

Tariff Impact on Oncology Supply Chains

Shifts in U.S. tariff policy directly affect supply costs and procurement frameworks throughout the brain and spinal cord cancer market. Stakeholders respond by expanding supplier networks, fostering localized manufacturing, and updating inventory approaches to ensure care continuity. Rising compliance demands and operational overhead require strategic changes in clinical trial logistics, sourcing, and domestic production, encouraging innovation in supply chain structure and operational agility.

Research Methodology & Data Sources

This market assessment uses a mixed-methods approach, drawing primary data from interviews with clinical stakeholders, supply chain leaders, and commercial executives. Complementary secondary research synthesizes findings from peer-reviewed literature, clinical registries, regulatory documents, and policy reviews, with expert panels refining insights for accuracy and relevance.

Why This Report Matters

  • Enables senior leadership to make targeted investments and operational decisions by delivering actionable segmentation analysis and regional insights tailored to the Brain & Spinal Cord Cancer Market.
  • Guides the alignment of translational research, real-world evidence strategies, and workforce development with evolving supply chain needs and commercialization objectives.
  • Clarifies the interplay between payer models, technological infrastructure, and distribution channels, driving informed choices that enhance access, value, and clinical outcomes.

Conclusion

This report delivers actionable insights for navigating the intricate clinical, operational, and policy dimensions of the Brain & Spinal Cord Cancer Market. A strategic focus on innovation, access, and operational resilience positions organizations to advance both patient outcomes and organizational objectives.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Brain & Spinal Cord Cancer Market, by Cancer Type
8.1. Astrocytoma
8.2. Ependymoma
8.3. Glioblastoma
8.4. Medulloblastoma
8.5. Meningioma
8.6. Oligodendroglioma
8.7. Schwannoma
9. Brain & Spinal Cord Cancer Market, by Treatment Type
9.1. Chemotherapy
9.1.1. Alkylating Agents
9.1.2. Nitrosoureas
9.1.3. Platinum Based Agents
9.2. Immunotherapy
9.2.1. CAR T Cell Therapy
9.2.2. Checkpoint Inhibitors
9.3. Radiation Therapy
9.3.1. External Beam Radiation
9.3.2. Proton Therapy
9.3.3. Stereotactic Radiosurgery
9.4. Supportive Care
9.5. Surgery
9.5.1. Craniotomy
9.5.2. Laser Ablation
9.5.3. Minimally Invasive Resection
9.6. Targeted Therapy
9.6.1. Kinase Inhibitors
9.6.2. Monoclonal Antibodies
10. Brain & Spinal Cord Cancer Market, by Patient Age Group
10.1. Adult
10.2. Geriatric
10.3. Pediatric
11. Brain & Spinal Cord Cancer Market, by End User
11.1. Ambulatory Surgical Centers
11.2. Cancer Clinics
11.3. Home Care Settings
11.4. Hospitals
12. Brain & Spinal Cord Cancer Market, by Distribution Channel
12.1. Clinic Pharmacies
12.2. Hospital Pharmacies
12.3. Online Pharmacies
12.4. Retail Pharmacies
12.5. Specialty Stores
13. Brain & Spinal Cord Cancer Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Brain & Spinal Cord Cancer Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Brain & Spinal Cord Cancer Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Brain & Spinal Cord Cancer Market
17. China Brain & Spinal Cord Cancer Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. AbbVie Inc.
18.6. Amgen Inc.
18.7. AstraZeneca PLC
18.8. Bayer AG
18.9. bluebird bio, Inc.
18.10. Bristol Myers Squibb Company
18.11. Dr. Reddy’s Laboratories Ltd.
18.12. Eisai Co., Ltd.
18.13. Eisai Inc.
18.14. F. Hoffmann-La Roche Ltd
18.15. Genentech, Inc.
18.16. GlaxoSmithKline PLC
18.17. Illumina, Inc.
18.18. Johnson & Johnson Services, Inc
18.19. Merck & Co., Inc.
18.20. Nektar Therapeutics
18.21. Novartis AG
18.22. Novocure Limited
18.23. Pfizer Inc.
18.24. Regeneron Pharmaceuticals, Inc.
18.25. Shimadzu Corporation
18.26. Siemens Healthineers
18.27. Teva Pharmaceutical Industries Ltd.
18.28. Y-mAbs Therapeutics A/S
List of Figures
FIGURE 1. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL BRAIN & SPINAL CORD CANCER MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CANCER TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY PATIENT AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES BRAIN & SPINAL CORD CANCER MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA BRAIN & SPINAL CORD CANCER MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY ASTROCYTOMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY ASTROCYTOMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY ASTROCYTOMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY EPENDYMOMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY EPENDYMOMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY EPENDYMOMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY GLIOBLASTOMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY GLIOBLASTOMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY GLIOBLASTOMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY MEDULLOBLASTOMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY MEDULLOBLASTOMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY MEDULLOBLASTOMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY MENINGIOMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY MENINGIOMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY MENINGIOMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY OLIGODENDROGLIOMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY OLIGODENDROGLIOMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY OLIGODENDROGLIOMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY SCHWANNOMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY SCHWANNOMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY SCHWANNOMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CHEMOTHERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CHEMOTHERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY ALKYLATING AGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY ALKYLATING AGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY ALKYLATING AGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY NITROSOUREAS, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY NITROSOUREAS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY NITROSOUREAS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY PLATINUM BASED AGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY PLATINUM BASED AGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY PLATINUM BASED AGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY IMMUNOTHERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY IMMUNOTHERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CAR T CELL THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CAR T CELL THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CAR T CELL THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CHECKPOINT INHIBITORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CHECKPOINT INHIBITORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CHECKPOINT INHIBITORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY RADIATION THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY RADIATION THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY RADIATION THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY RADIATION THERAPY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY EXTERNAL BEAM RADIATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY EXTERNAL BEAM RADIATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY EXTERNAL BEAM RADIATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY PROTON THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY PROTON THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY PROTON THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY STEREOTACTIC RADIOSURGERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY STEREOTACTIC RADIOSURGERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY STEREOTACTIC RADIOSURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY SUPPORTIVE CARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY SUPPORTIVE CARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY SUPPORTIVE CARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY SURGERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY SURGERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY SURGERY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CRANIOTOMY, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CRANIOTOMY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CRANIOTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY LASER ABLATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY LASER ABLATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY LASER ABLATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY MINIMALLY INVASIVE RESECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY MINIMALLY INVASIVE RESECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY MINIMALLY INVASIVE RESECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TARGETED THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TARGETED THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TARGETED THERAPY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY KINASE INHIBITORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY KINASE INHIBITORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY KINASE INHIBITORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CANCER CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CANCER CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CANCER CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CLINIC PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CLINIC PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CLINIC PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY SPECIALTY STORES, BY REGION, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY SPECIALTY STORES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY SPECIALTY STORES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 127. AMERICAS BRAIN & SPINAL CORD CANCER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 128. AMERICAS BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 129. AMERICAS BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 130. AMERICAS BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
TABLE 131. AMERICAS BRAIN & SPINAL CORD CANCER MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 132. AMERICAS BRAIN & SPINAL CORD CANCER MARKET SIZE, BY RADIATION THERAPY, 2018-2032 (USD MILLION)
TABLE 133. AMERICAS BRAIN & SPINAL CORD CANCER MARKET SIZE, BY SURGERY, 2018-2032 (USD MILLION)
TABLE 134. AMERICAS BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TARGETED THERAPY, 2018-2032 (USD MILLION)
TABLE 135. AMERICAS BRAIN & SPINAL CORD CANCER MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 136. AMERICAS BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 137. AMERICAS BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 138. NORTH AMERICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 139. NORTH AMERICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 140. NORTH AMERICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 141. NORTH AMERICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
TABLE 142. NORTH AMERICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 143. NORTH AMERICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY RADIATION THERAPY, 2018-2032 (USD MILLION)
TABLE 144. NORTH AMERICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY SURGERY, 2018-2032 (USD MILLION)
TABLE 145. NORTH AMERICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TARGETED THERAPY, 2018-2032 (USD MILLION)
TABLE 146. NORTH AMERICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 147. NORTH AMERICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 148. NORTH AMERICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 149. LATIN AMERICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 150. LATIN AMERICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 151. LATIN AMERICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 152. LATIN AMERICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
TABLE 153. LATIN AMERICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 154. LATIN AMERICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY RADIATION THERAPY, 2018-2032 (USD MILLION)
TABLE 155. LATIN AMERICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY SURGERY, 2018-2032 (USD MILLION)
TABLE 156. LATIN AMERICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TARGETED THERAPY, 2018-2032 (USD MILLION)
TABLE 157. LATIN AMERICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 158. LATIN AMERICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 159. LATIN AMERICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY RADIATION THERAPY, 2018-2032 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY SURGERY, 2018-2032 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TARGETED THERAPY, 2018-2032 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 171. EUROPE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 172. EUROPE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 173. EUROPE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 174. EUROPE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
TABLE 175. EUROPE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 176. EUROPE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY RADIATION THERAPY, 2018-2032 (USD MILLION)
TABLE 177. EUROPE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY SURGERY, 2018-2032 (USD MILLION)
TABLE 178. EUROPE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TARGETED THERAPY, 2018-2032 (USD MILLION)
TABLE 179. EUROPE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 180. EUROPE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 181. EUROPE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 182. MIDDLE EAST BRAIN & SPINAL CORD CANCER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 183. MIDDLE EAST BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 184. MIDDLE EAST BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 185. MIDDLE EAST BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
TABLE 186. MIDDLE EAST BRAIN & SPINAL CORD CANCER MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 187. MIDDLE EAST BRAIN & SPINAL CORD CANCER MARKET SIZE, BY RADIATION THERAPY, 2018-2032 (USD MILLION)
TABLE 188. MIDDLE EAST BRAIN & SPINAL CORD CANCER MARKET SIZE, BY SURGERY, 2018-2032 (USD MILLION)
TABLE 189. MIDDLE EAST BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TARGETED THERAPY, 2018-2032 (USD MILLION)
TABLE 190. MIDDLE EAST BRAIN & SPINAL CORD CANCER MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 191. MIDDLE EAST BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 192. MIDDLE EAST BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 193. AFRICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 194. AFRICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 195. AFRICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 196. AFRICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
TABLE 197. AFRICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 198. AFRICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY RADIATION THERAPY, 2018-2032 (USD MILLION)
TABLE 199. AFRICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY SURGERY, 2018-2032 (USD MILLION)
TABLE 200. AFRICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TARGETED THERAPY, 2018-2032 (USD MILLION)
TABLE 201. AFRICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 202. AFRICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 203. AFRICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 204. ASIA-PACIFIC BRAIN & SPINAL CORD CANCER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 205. ASIA-PACIFIC BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 206. ASIA-PACIFIC BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 207. ASIA-PACIFIC BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
TABLE 208. ASIA-PACIFIC BRAIN & SPINAL CORD CANCER MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 209. ASIA-PACIFIC BRAIN & SPINAL CORD CANCER MARKET SIZE, BY RADIATION THERAPY, 2018-2032 (USD MILLION)
TABLE 210. ASIA-PACIFIC BRAIN & SPINAL CORD CANCER MARKET SIZE, BY SURGERY, 2018-2032 (USD MILLION)
TABLE 211. ASIA-PACIFIC BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TARGETED THERAPY, 2018-2032 (USD MILLION)
TABLE 212. ASIA-PACIFIC BRAIN & SPINAL CORD CANCER MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 213. ASIA-PACIFIC BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 214. ASIA-PACIFIC BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 215. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 216. ASEAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 217. ASEAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 218. ASEAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 219. ASEAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
TABLE 220. ASEAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 221. ASEAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY RADIATION THERAPY, 2018-2032 (USD MILLION)
TABLE 222. ASEAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY SURGERY, 2018-2032 (USD MILLION)
TABLE 223. ASEAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TARGETED THERAPY, 2018-2032 (USD MILLION)
TABLE 224. ASEAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 225. ASEAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 226. ASEAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 227. GCC BRAIN & SPINAL CORD CANCER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 228. GCC BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 229. GCC BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 230. GCC BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
TABLE 231. GCC BRAIN & SPINAL CORD CANCER MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 232. GCC BRAIN & SPINAL CORD CANCER MARKET SIZE, BY RADIATION THERAPY, 2018-2032 (USD MILLION)
TABLE 233. GCC BRAIN & SPINAL CORD CANCER MARKET SIZE, BY SURGERY, 2018-2032 (USD MILLION)
TABLE 234. GCC BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TARGETED THERAPY, 2018-2032 (USD MILLION)
TABLE 235. GCC BRAIN & SPINAL CORD CANCER MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 236. GCC BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 237. GCC BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 238. EUROPEAN UNION BRAIN & SPINAL CORD CANCER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 239. EUROPEAN UNION BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 240. EUROPEAN UNION BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 241. EUROPEAN UNION BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
TABLE 242. EUROPEAN UNION BRAIN & SPINAL CORD CANCER MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 243. EUROPEAN UNION BRAIN & SPINAL CORD CANCER MARKET SIZE, BY RADIATION THERAPY, 2018-2032 (USD MILLION)
TABLE 244. EUROPEAN UNION BRAIN & SPINAL CORD CANCER MARKET SIZE, BY SURGERY, 2018-2032 (USD MILLION)
TABLE 245. EUROPEAN UNION BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TARGETED THERAPY, 2018-2032 (USD MILLION)
TABLE 246. EUROPEAN UNION BRAIN & SPINAL CORD CANCER MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 247. EUROPEAN UNION BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 248. EUROPEAN UNION BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 249. BRICS BRAIN & SPINAL CORD CANCER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 250. BRICS BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 251. BRICS BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 252. BRICS BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
TABLE 253. BRICS BRAIN & SPINAL CORD CANCER MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 254. BRICS BRAIN & SPINAL CORD CANCER MARKET SIZE, BY RADIATION THERAPY, 2018-2032 (USD MILLION)
TABLE 255. BRICS BRAIN & SPINAL CORD CANCER MARKET SIZE, BY SURGERY, 2018-2032 (USD MILLION)
TABLE 256. BRICS BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TARGETED THERAPY, 2018-2032 (USD MILLION)
TABLE 257. BRICS BRAIN & SPINAL CORD CANCER MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 258. BRICS BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 259. BRICS BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 260. G7 BRAIN & SPINAL CORD CANCER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 261. G7 BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 262. G7 BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 263. G7 BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
TABLE 264. G7 BRAIN & SPINAL CORD CANCER MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 265. G7 BRAIN & SPINAL CORD CANCER MARKET SIZE, BY RADIATION THERAPY, 2018-2032 (USD MILLION)
TABLE 266. G7 BRAIN & SPINAL CORD CANCER MARKET SIZE, BY SURGERY, 2018-2032 (USD MILLION)
TABLE 267. G7 BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TARGETED THERAPY, 2018-2032 (USD MILLION)
TABLE 268. G7 BRAIN & SPINAL CORD CANCER MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 269. G7 BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 270. G7 BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 271. NATO BRAIN & SPINAL CORD CANCER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 272. NATO BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 273. NATO BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 274. NATO BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
TABLE 275. NATO BRAIN & SPINAL CORD CANCER MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 276. NATO BRAIN & SPINAL CORD CANCER MARKET SIZE, BY RADIATION THERAPY, 2018-2032 (USD MILLION)
TABLE 277. NATO BRAIN & SPINAL CORD CANCER MARKET SIZE, BY SURGERY, 2018-2032 (USD MILLION)
TABLE 278. NATO BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TARGETED THERAPY, 2018-2032 (USD MILLION)
TABLE 279. NATO BRAIN & SPINAL CORD CANCER MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 280. NATO BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 281. NATO BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 282. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 283. UNITED STATES BRAIN & SPINAL CORD CANCER MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 284. UNITED STATES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 285. UNITED STATES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 286. UNITED STATES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
TABLE 287. UNITED STATES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 288. UNITED STATES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY RADIATION THERAPY, 2018-2032 (USD MILLION)
TABLE 289. UNITED STATES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY SURGERY, 2018-2032 (USD MILLION)
TABLE 290. UNITED STATES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TARGETED THERAPY, 2018-2032 (USD MILLION)
TABLE 291. UNITED STATES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 292. UNITED STATES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 293. UNITED STATES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 294. CHINA BRAIN & SPINAL CORD CANCER MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 295. CHINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 296. CHINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 297. CHINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
TABLE 298. CHINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 299. CHINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY RADIATION THERAPY, 2018-2032 (USD MILLION)
TABLE 300. CHINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY SURGERY, 2018-2032 (USD MILLION)
TABLE 301. CHINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TARGETED THERAPY, 2018-2032 (USD MILLION)
TABLE 302. CHINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 303. CHINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 304. CHINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Brain & Spinal Cord Cancer market report include:
  • AbbVie Inc.
  • Amgen Inc.
  • AstraZeneca PLC
  • Bayer AG
  • bluebird bio, Inc.
  • Bristol Myers Squibb Company
  • Dr. Reddy’s Laboratories Ltd.
  • Eisai Co., Ltd.
  • Eisai Inc.
  • F. Hoffmann-La Roche Ltd
  • Genentech, Inc.
  • GlaxoSmithKline PLC
  • Illumina, Inc.
  • Johnson & Johnson Services, Inc
  • Merck & Co., Inc.
  • Nektar Therapeutics
  • Novartis AG
  • Novocure Limited
  • Pfizer Inc.
  • Regeneron Pharmaceuticals, Inc.
  • Shimadzu Corporation
  • Siemens Healthineers
  • Teva Pharmaceutical Industries Ltd.
  • Y-mAbs Therapeutics A/S

Table Information

Report AttributeDetails
No. of Pages188
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 4.46 Billion
Forecasted Market Value ( USD ) by 2032 $ 6.33 Billion
Compound Annual Growth Rate5.9%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Spinal Cord Stimulators Market - Global Strategic Business Report - Product Image

Spinal Cord Stimulators Market - Global Strategic Business Report

  • Report
  • 387 Pages
  • Global
From
Acute Spinal Cord Injury Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Acute Spinal Cord Injury Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Acute Spinal Cord Injury Market - Global Strategic Business Report - Product Image

Acute Spinal Cord Injury Market - Global Strategic Business Report

  • Report
  • 274 Pages
  • Global
From
Spinal Cord Neurostimulation Implant Market - Global Forecast 2026-2032 - Product Image

Spinal Cord Neurostimulation Implant Market - Global Forecast 2026-2032

  • Report
  • 180 Pages
  • Global
From
Acute Spinal Cord Injury Market Report 2025 - Product Image

Acute Spinal Cord Injury Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.